Figure 1From: Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndromeFasting triglyceride levels [mg/dl] in subjects without (AdipoR2) and with the AdipoR2 SNP cluster (AdipoR2-SNP) after 12 weeks of placebo treatment. Data are presented as box plot (minimum, 25% quartile, median, 75% quartile, maximum).Back to article page